190 related articles for article (PubMed ID: 35896929)
1. Genes of the Ubiquitin Proteasome System Qualify as Differential Markers in Malignant Glioma of Astrocytic and Oligodendroglial Origin.
Vriend J; Klonisch T
Cell Mol Neurobiol; 2023 May; 43(4):1425-1452. PubMed ID: 35896929
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin Proteasome Gene Signatures in Ependymoma Molecular Subtypes.
Vriend J; Thanasupawat T; Sinha N; Klonisch T
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293188
[TBL] [Abstract][Full Text] [Related]
3. The E3 ubiquitin ligase HUWE1 acts through the N-Myc-DLL1-NOTCH1 signaling axis to suppress glioblastoma progression.
Yuan Y; Wang LH; Zhao XX; Wang J; Zhang MS; Ma QH; Wei S; Yan ZX; Cheng Y; Chen XQ; Zou HB; Ge J; Wang Y; Zhang X; Cui YH; Luo T; Bian XW
Cancer Commun (Lond); 2022 Sep; 42(9):868-886. PubMed ID: 35848447
[TBL] [Abstract][Full Text] [Related]
4. In vitro autoubiquitination activity of E3 ubiquitin ligases of the N-degron pathway.
Sandmann A; Dissmeyer N
Methods Enzymol; 2023; 686():205-220. PubMed ID: 37532400
[TBL] [Abstract][Full Text] [Related]
5. A Survey on the Expression of the Ubiquitin Proteasome System Components HECT- and RBR-E3 Ubiquitin Ligases and E2 Ubiquitin-Conjugating and E1 Ubiquitin-Activating Enzymes during Human Brain Development.
Magnati S; Alladio E; Bracco E
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397039
[TBL] [Abstract][Full Text] [Related]
6. A patent review of the ubiquitin ligase system: 2015-2018.
Li X; Elmira E; Rohondia S; Wang J; Liu J; Dou QP
Expert Opin Ther Pat; 2018 Dec; 28(12):919-937. PubMed ID: 30449221
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin ligases and medulloblastoma: genetic markers of the four consensus subgroups identified through transcriptome datasets.
Vriend J; Rastegar M
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165839. PubMed ID: 32445667
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin Proteasome Pathway Transcriptome in Epithelial Ovarian Cancer.
Vriend J; Nachtigal MW
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34071321
[TBL] [Abstract][Full Text] [Related]
9. A label-free quantitative proteomics strategy to identify E3 ubiquitin ligase substrates targeted to proteasome degradation.
Burande CF; Heuzé ML; Lamsoul I; Monsarrat B; Uttenweiler-Joseph S; Lutz PG
Mol Cell Proteomics; 2009 Jul; 8(7):1719-27. PubMed ID: 19376791
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin-Proteasome Pathway and Muscle Atrophy.
Khalil R
Adv Exp Med Biol; 2018; 1088():235-248. PubMed ID: 30390254
[TBL] [Abstract][Full Text] [Related]
11. Perilous journey: a tour of the ubiquitin-proteasome system.
Kleiger G; Mayor T
Trends Cell Biol; 2014 Jun; 24(6):352-9. PubMed ID: 24457024
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of Anaphase Promoting Complex/Cyclosome (APC/C) E3 ubiquitin ligases in tumorigenesis.
Zhang J; Wan L; Dai X; Sun Y; Wei W
Biochim Biophys Acta; 2014 Apr; 1845(2):277-93. PubMed ID: 24569229
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases.
Villeneuve NF; Lau A; Zhang DD
Antioxid Redox Signal; 2010 Dec; 13(11):1699-712. PubMed ID: 20486766
[TBL] [Abstract][Full Text] [Related]
14. Degradation of misfolded protein in the cytoplasm is mediated by the ubiquitin ligase Ubr1.
Eisele F; Wolf DH
FEBS Lett; 2008 Dec; 582(30):4143-6. PubMed ID: 19041308
[TBL] [Abstract][Full Text] [Related]
15. Identification and Characterization of Physiological Pairing of E2 Ubiquitin-Conjugating Enzymes and E3 Ubiquitin Ligases.
Brillada C; Trujillo M
Methods Mol Biol; 2023; 2581():13-29. PubMed ID: 36413307
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of Tumor Suppressive Function of FBXO16 Ubiquitin Ligase Activates Wnt Signaling In Glioblastoma.
Khan M; Muzumdar D; Shiras A
Neoplasia; 2019 Jan; 21(1):106-116. PubMed ID: 30530053
[TBL] [Abstract][Full Text] [Related]
17. Targeting the ubiquitin pathway for cancer treatment.
Liu J; Shaik S; Dai X; Wu Q; Zhou X; Wang Z; Wei W
Biochim Biophys Acta; 2015 Jan; 1855(1):50-60. PubMed ID: 25481052
[TBL] [Abstract][Full Text] [Related]
18. E2-E3 ubiquitin enzyme pairing - partnership in provoking or mitigating cancers.
Chang SC; Zhang BX; Ding JL
Biochim Biophys Acta Rev Cancer; 2022 Mar; 1877(2):188679. PubMed ID: 35074437
[TBL] [Abstract][Full Text] [Related]
19. Skp2 in the ubiquitin-proteasome system: A comprehensive review.
Asmamaw MD; Liu Y; Zheng YC; Shi XJ; Liu HM
Med Res Rev; 2020 Sep; 40(5):1920-1949. PubMed ID: 32391596
[TBL] [Abstract][Full Text] [Related]
20. Timer-based proteomic profiling of the ubiquitin-proteasome system reveals a substrate receptor of the GID ubiquitin ligase.
Kong KE; Fischer B; Meurer M; Kats I; Li Z; Rühle F; Barry JD; Kirrmaier D; Chevyreva V; San Luis BJ; Costanzo M; Huber W; Andrews BJ; Boone C; Knop M; Khmelinskii A
Mol Cell; 2021 Jun; 81(11):2460-2476.e11. PubMed ID: 33974913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
